Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders

Archives of Neurology

Volumn 55, Issue 10, 1998, Pages 1313-1319

  Litvan, Irene ^a,e,f   Paulsen, Jane S ^b   Mega, Michael S ^c   Cummings, Jeffrey L ^c,d  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGITATION; ANXIETY; APATHY; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; DISEASE DURATION; EUPHORIA; FRONTAL CORTEX; HUMAN; HUNTINGTON CHOREA; HYPERKINESIA; HYPOKINESIA; IRRITABILITY; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; ORBITAL CORTEX; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

AGED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; MIDDLE AGED; MOVEMENT DISORDERS; NEURODEGENERATIVE DISEASES; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 0031718450     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.10.1313     Document Type: Article

References (57)

1. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9: 357-381.
2. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990;13:281-285.
3. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. In: Uylungs HBM, Van Eden CG, De Bruin JPC, Corner MA, Feenstra MGP, eds. The Prefrontal Cortex, Its Structure, Function and Pathology. Amsterdam, the Netherlands: Elsevier Science Publishers; 1990:266-271.
4. Albin RL, Young AB, Penney JB. The functional anatomy of disorders of the basal ganglia. Trends Neurosci. 1995;18:63-64.
5. Graybiel AM. The basal ganglia. Trends Neurosci. 1995;18:60-62.
6. Brown LL, Schneider JS, Lidsky TI. Sensory and cognitive functions of the basal ganglia. Curr Opin Neurobiol. 1997;7:157-163.
7. Feger J. Updating the functional model of the basal ganglia. Trends Neurosci. 1997;20:152-153.
8. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990;13:266-271.
9. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci. 1994;6:358-370.
10. Cummings JL. Anatomic and behavioral aspects of frontal-subcortical circuits. Ann N Y Acad Sci. 1995;769:1-13.
11. Litvan I. Extrapyramidal disorders and frontal lobe function. In: Miller BL, Cummings JL, eds. The Frontal Lobes. New York, NY: Guilford Press. In press.
12. Hof PR, Delacourte A, Bouras C. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (Berl). 1992;84:45-51.
13. Verny M, Duyckaerts C, Agid Y, Hauw JJ. The significance of cortical pathology in progressive supranuclear palsy: clinicopathological data in 10 cases. Brain. 1996;119:1123-1136.
14. Albert ML, Feldman RG, Willis AL. The "subcortical dementia" of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1974;37:121-130.
15. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1992;4:134-139.
16. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992; 55:377-382.
17. Chiu HF. Psychiatric aspects of progressive supranuclear palsy. Gen Hosp Psychiatry. 1995;17:135-143.
18. Cummings JL, Diaz C, Levy M, Binetti G, Litvan I. Neuropsychiatric syndromes in neurodegenerative diseases: frequency and significance. Sem Clin Neuropsychiatry. 1996;1:241-247.
19. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology. 1996;47:1184-1189.
20. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein PH. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
22. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996;47:1-9.
23. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994;44:2015-2019.
24. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the mental state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
25. Mattis S. Mental status examination for organic mental syndrome in the elderly. In: Bellak L, Karasu TB, eds. Geriatric Psychiatry. New York, NY: Grune & Stratton Inc; 1976.
26. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord. 1996;11:136-142.
27. Fahn S, Elton RL, and Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CO, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. Vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163, 293-304.
28. Efron B, Tibshirani R. Statistical data analysis in the computer age. Science. 1991; 253:390-395.
29. Cummings JL, Cunningham K. Obsessive-compulsive disorder in Huntington's disease. Biol Psychiatry. 1992;31:263-270.
30. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993; 50:873-880.
31. Baxter LR, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Arch Gen Psychiatry. 1987; 44:211-218.
32. Swedo SE, Leonard HL, Schapiro MB, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:690-694.
33. McGuire PK, Bench CJ, Frith CD, Marks IM, Frackowiak RS, Dolan RJ. Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry. 1994;164: 459-468.
34. Machlin SR, Harris GJ, Pearlson GD, Hoehn-Saric R, Jeffery P, Camargo EE. Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: a SPECT study. Am J Psychiatry. 1991;148:1240-1242.
35. Hoehn-Saric R, Pearlson GD, Harris GJ, Machlin SR, Camargo EE. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry. 1991;148:1243-1245.
36. Kuhl DE, Phelps ME, Markham CH, Metter EJ, Riege WH, Winter J. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol. 1982;12:425-434.
37. Young BA, Penney JB, Starosta-Rubinstein S, et al. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol. 1986;20:296-303.
38. 2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain. 1996;119:2085-2095.
39. Gomez-Tortosa E, Arias Navalon JA, del Barrio Alba A, et al. Relation between frontal lobe blood flow and cognitive performance in Huntington's disease. Neurologia. 1996;11:251-256.
40. Weinberger DR, Berman KF, Iadarola M, Driesen N, Zec RF. Prefrontal cortical blood flow and cognitive function in Huntington's disease. J Neurol Neurosurg Psychiatry. 1988;51:94-104.
41. Agid Y, Javoy-Agid F, Ruberg M, et al. Progressive supranuclear palsy: anatomoclinical and biochemical considerations. Adv Neurol. 1987;45:191-206.
42. Blin J, Baron JC, Dubois B, et al. Positron emission tomography study in progressive supranuclear palsy: brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol. 1990;47:747-752.
43. Blin J, Ruberg M, Baron JC. Positron emission tomography studies. In: Litvan I, Agid Y, eds. Progressive Supranuclear Palsy: Clinical and Research Approaches. New York, NY: Oxford University Press; 1992:155-168.
44. Brooks DJ, Ibanez V, Sawle GV, et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol. 1990;28:547-555.
45. 2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol. 1992;31:184-192.
46. Brooks DJ. PET studies in progressive supranuclear palsy. J Neural Transm Suppl. 1994;42:119-134.
47. D'Antona R, Baron JC, Samson Y, et al. Subcortical dementia: frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain. 1985;08:785-799.
48. Braak H, Jellinger K, Braak E, Bohl J. Allocortical neurofibrillary changes in progressive supranuclear palsy. Acta Neuropathol (Berl). 1992;4:478-483.
49. Brandel JP, Hirsch EC, Malessa S, Duyckaerts C, Cervera P, Agid Y. Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy. Neuroscience. 1991;1:25-31.
50. Jellinger KA, Bancher C. Neuropathology. In: Litvan I, Agid Y, eds. Progressive Supranuclear Palsy: Clinical and Research Approaches. New York, NY: Oxford University Press; 1992:44-88.
51. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain. 1991;14:2095-2122.
52. Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbin TW. Executive and mnemonic functions in early Huntington's disease. Brain. 1996;119: 1633-1645.
53. Mayberg HS, Starkstein SE, Peyser CE, Brandt J, Dannals RF, Folstein SE. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology. 1992;42:1791-1797.
54. Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology. 1991;41:634-643.
55. Robbins TW, James M, Owen AM, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry. 1994;57:79-88.
56. Chesselet MF, Delfs JM. Basal ganglia and movement disorders: an update. Trends Neurosci. 1996;19:417-422.
57. Obeso JA, Rodriguez MC, DeLong MR. Basal ganglia pathophysiology: a critical review. Adv Neurol. 1997;74:3-18.